Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Annette Rieg (Aachen, Germany), Said Suleiman, Mark Coburn, Julia Krabbe, Rolf Rossaint, Christian Martin, Annette Rieg. Argon reduces the ET-1 induced increase of segmental PVR and the generation of lung edema. Eur Respir J 2016; 48: Suppl. 60, 2482

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension correlates with increase in pulmonary interstitial pressure and decreased capillary patency Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Interstitial pressure and lung oedema in chronic hypoxia Source: Eur Respir J 2011; 37: 943-949 Year: 2011 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension Source: International Congress 2016 – Connective tissue disorders Year: 2016 MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Macitentan reduces progression of TGF-ß1-induced pulmonary fibrosis and pulmonary hypertension Source: Eur Respir J, 52 (2) 1701857; 10.1183/13993003.01857-2017 Year: 2018 Sildenafil is a potent pulmonary vasodilator in pulmonary hypertension associated with interstitial lung disease: impact on gas exchange properties Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002 Caspase inhibition reduces severe pulmonary hypertension in the AdTGF-1β/SU5416 model of angioproliferative pulmonary hypertension and lung fibrosis Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Hypoxia-induced pulmonary edema Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice Source: International Congress 2016 – ILD pathogenesis Year: 2016 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis Source: Eur Respir J 2013; 41: 1324-1330 Year: 2013 Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Is pulmonary hypertension associated with a leakage or an activation of endothelial cells? Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1483-1485 Year: 2010